Anila D’Mello is an assistant professor and Jon Heighten Scholar in Autism Research in the Department of Psychiatry and O’Donnell Brain Institute at the University of Texas Southwestern in Dallas.
Anila D’Mello
Assistant professor
University of Texas Southwestern
From this contributor
How scientists can counteract their unwitting contributions to autism’s sex bias
Common diagnostic and research practices may be adding to autism’s sex bias, but there are some simple steps scientists can take to counteract it.
How scientists can counteract their unwitting contributions to autism’s sex bias
By
Anila D’Mello
20 December 2022 | 7 min read
Explore more from The Transmitter
Double-duty neurons in primary olfactory cortex pick up on more than just scent
The cells recognize not only odors, such as bananas and black licorice—but also images and words associated with those smells, according to single-neuron recordings from 17 people.
Double-duty neurons in primary olfactory cortex pick up on more than just scent
The cells recognize not only odors, such as bananas and black licorice—but also images and words associated with those smells, according to single-neuron recordings from 17 people.
By
Angie Voyles Askham
9 October 2024 | 7 min read
How neuroscience comics add KA-POW! to the field: Q&A with Kanaka Rajan
The artistic approach can help explain complex ideas frame by frame without diluting the science, Rajan says.
How neuroscience comics add KA-POW! to the field: Q&A with Kanaka Rajan
The artistic approach can help explain complex ideas frame by frame without diluting the science, Rajan says.
By
Olivia Gieger
9 October 2024 | 7 min read
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
By
Brendan Borrell, Ellie Kincaid
8 October 2024 | 3 min read